Skip to content
Besifloxacin
Besivance (besifloxacin) is a small molecule pharmaceutical. Besifloxacin was first approved as Besivance on 2009-05-28. It is used to treat bacterial conjunctivitis, bacterial infections, and protozoan infections in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
eye diseasesD005128
Trade Name
FDA
EMA
Besivance
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Besifloxacin hydrochloride
Tradename
Company
Number
Date
Products
BESIVANCEBausch Health CompaniesN-022308 RX2009-05-28
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
besivanceNew Drug Application2022-02-02
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial conjunctivitisEFO_1000829D003234H10.0
bacterial infections—D001424A49
protozoan infections—D011528B50-B64
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Besifloxacin Hydrochloride, Besivance, Bausch And Lomb
84815262031-01-09DP
84153422030-11-07U-80
86040202030-03-12DP
89370622029-11-13U-80
ATC Codes
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AE: Fluoroquinolone antiinfectives, ophthalmologic
— S01AE08: Besifloxacin
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I10————11
Marfan syndromeD008382Orphanet_558Q87.4————11
Bicuspid aortic valve diseaseD000082882————11
Aortic aneurysmD001014EFO_0001666I71.9————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBESIFLOXACIN
INNbesifloxacin
Description
Besifloxacin is a member of quinolines.
Classification
Small molecule
Drug classantibacterials (quinolone derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1
Identifiers
PDB—
CAS-ID141388-76-3
RxCUI819911
ChEMBL IDCHEMBL1201760
ChEBI ID—
PubChem CID10178705
DrugBankDB06771
UNII IDBFE2NBZ7NX (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 364 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
131 adverse events reported
View more details